open access

Vol 65, No 8 (2007)
Other
Published online: 2007-08-29
Submitted: 2012-12-28
Get Citation

Original article
Pulmonary function test abnormalities in the elderly with systolic heart failure

Rafał Kurzawa, Tomasz Baron, Tomasz Grodzicki
Kardiol Pol 2007;65(8):875-880.

open access

Vol 65, No 8 (2007)
Other
Published online: 2007-08-29
Submitted: 2012-12-28

Abstract

Background: An association between chronic heart failure (CHF) and pulmonary function abnormalities is clinicaly important. Spirometry is frequently used to evaluate lung function.
Aim: To evaluate some spirometric parameters in the elderly with newly diagnosed or known systolic CHF.
Methods: The study group consisted of 110 patients (74 men – 67.3%) who underwent echocardiography as well as spirometry with reversibility test. Heart failure was diagnosed using the guidelines of the European Society of Cardiology and Framingham criteria. The average age of the patients was 68.5±8.9 years. Smokers constituted 54.5% of the group. Concomittant deseaes included arterial hypertension (86.4%), diabetes type 2 (20.9%), and myocardial infarction (49.1%). At the beginning of the study, 54.5% of the patients had already been taking beta-blockers, 84.5% angiotensin-converting enzyme inhibitors, 83.6% diuretics, 30% calcium channel blockers, and 92.7% aspirin. Echocardiography revealed left ventricular ejection fraction (LVEF) below 45% in 74 (67.3%) patients.
Results: All analysed spirometric parameters were abnormal in CHF patients. A multivariable analysis revealed that age, smoking and LVEF were the only independent parameters which significantly effected FEV1 – one of the most important spirometric parameters.
Conclusions: In patients with systolic CHF, independently of the treatment, mixed ventilation disorders were observed, which had a positive reversibility test. Apart from impaired LVEF, older age as well as smoking significantly influenced the deterioration of ventilatory parameters.

Abstract

Background: An association between chronic heart failure (CHF) and pulmonary function abnormalities is clinicaly important. Spirometry is frequently used to evaluate lung function.
Aim: To evaluate some spirometric parameters in the elderly with newly diagnosed or known systolic CHF.
Methods: The study group consisted of 110 patients (74 men – 67.3%) who underwent echocardiography as well as spirometry with reversibility test. Heart failure was diagnosed using the guidelines of the European Society of Cardiology and Framingham criteria. The average age of the patients was 68.5±8.9 years. Smokers constituted 54.5% of the group. Concomittant deseaes included arterial hypertension (86.4%), diabetes type 2 (20.9%), and myocardial infarction (49.1%). At the beginning of the study, 54.5% of the patients had already been taking beta-blockers, 84.5% angiotensin-converting enzyme inhibitors, 83.6% diuretics, 30% calcium channel blockers, and 92.7% aspirin. Echocardiography revealed left ventricular ejection fraction (LVEF) below 45% in 74 (67.3%) patients.
Results: All analysed spirometric parameters were abnormal in CHF patients. A multivariable analysis revealed that age, smoking and LVEF were the only independent parameters which significantly effected FEV1 – one of the most important spirometric parameters.
Conclusions: In patients with systolic CHF, independently of the treatment, mixed ventilation disorders were observed, which had a positive reversibility test. Apart from impaired LVEF, older age as well as smoking significantly influenced the deterioration of ventilatory parameters.
Get Citation

Keywords

spirometry; heart failure; elderly

About this article
Title

Original article
Pulmonary function test abnormalities in the elderly with systolic heart failure

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 65, No 8 (2007)

Pages

875-880

Published online

2007-08-29

Bibliographic record

Kardiol Pol 2007;65(8):875-880.

Keywords

spirometry
heart failure
elderly

Authors

Rafał Kurzawa
Tomasz Baron
Tomasz Grodzicki

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl